Hsbc Holdings »

Poseida Therapeutics I shares owned by Hsbc Holdings

Quarter-by-quarter ownership of Poseida Therapeutics I (PSTX) shares owned by Hsbc Holdings from 13F filings

Historical chart of Hsbc Holdings investment in Poseida Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Poseida Therapeutics I held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Poseida Therapeutics I by Hsbc Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $161k 49k 3.29
2023-09-30 $116k 49k 2.38

More positions owned by Hsbc Holdings

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Visa Com Cl A (V)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Hsbc Holdings

Top funds holding Poseida Therapeutics I

Pentwater Capital Management
Vanguard Group
Aisling Capital Management
William Blair $ Company
Millennium Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Goldman Sachs Group
Jacobs Levy Equity Management
Connor, Clark & Lunn Investment Management
Point72 Asset Management
MCF Advisors
Bank of America Corporation
Bank of New York Mellon
Barclays

View all funds holding Poseida Therapeutics I